Methohexital: Clinical Trials

10 trials of Methohexital, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated. 5 Not applicable, 4 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Terminated 1
Phase 44Completed 4
Early Phase 11Completed 1

Follow Methohexital: new trials by email Literature Review of Methohexital trials Research Report on Methohexital

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
Methohexital, Ketofol - ECT, Depression
Phase 4CompletedMedical University of Vienna562022-11-012026-10-07
Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
Propofol, Methohexital - Atrial Fibrillation, Atrial Flutter
Phase 4CompletedWake Forest University Health Sciences732020-04-292023-11-13
EEG Characteristics in ECT
Ketamine, Methohexital - Electroconvulsive Therapy, Direct Current Electroencephalogram
Early Phase 1CompletedUniversity of New Mexico112019-10-012024-10-26
Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs
Methohexital, Propofol - Hypotension, Anesthesia
Not applicableCompletedMilton S. Hershey Medical Center512016-08-012025-01-28
Ketamine Anesthesia for Improvement of Depression in ECT
Ketamine, Methohexital - Major Depressive Disorder
Not applicableCompletedVA Puget Sound Health Care System522016-03-012018-06-06
Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time
Ketamine, Methohexital - Post-anesthesia Recovery, Orientation
Not applicableCompletedUniversity of New Mexico202011-08-012014-12-30
Ketamine Anesthesia in Electroconvulsive Therapy
Ketamine, methohexital - Depression
Not applicableCompletedMayo Clinic382011-05-012013-08-08
Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Ketamine, Methohexital - Unipolar Depression, Bipolar Depression
Phase 4CompletedNorthwell Health312010-06-012023-03-09
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Ketamine, Methohexital - Major Depression, Bipolar Depression
Not applicableTerminatedJames Murrough32010-04-012013-08-30
Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
ECT Mecta 5000M, Methohexitone, Suxamethonium - Depression
Phase 4CompletedSt Patrick's Hospital, Ireland1382008-05-012018-11-14

Conditions studied

Depression (5)  ·  Bipolar Disorder (2)  ·  Depressive Disorder, Major (2)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Hypotension (1)  ·  Orientation, Spatial (1)

Sponsors

University of New Mexico (2)  ·  James Murrough (1)  ·  Mayo Clinic (1)  ·  Medical University of Vienna (1)  ·  Milton S. Hershey Medical Center (1)  ·  Northwell Health (1)  ·  St Patrick's Hospital, Ireland (1)  ·  VA Puget Sound Health Care System (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (8)  ·  Austria (1)  ·  Ireland (1)

Top investigators

Anna Borisovskaya, MD (1)  ·  Anthony Bonavia, MD (1)  ·  Declan M McLoughlin, PhD (1)  ·  Elijah Beaty, MD (1)  ·  Georgios Petrides, M.D. (1)  ·  Irene Rozet, MD (1)  ·  James W Murrough, MD (1)  ·  Keith Rasmussen, MD (1)  ·  Tony Yen, MD (1)

Results publications

PMID 34623633, PMID 34752484, PMID 36129031, PMID 39428602